TECX:NASDAQTectonic Therapeutic, Inc. Analysis
Data as of 2026-09-01 - not real-time
$29.94
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Tectonic Therapeutic, Inc. is bullish at $29.94, with short-term averages leading the long-term ones. The last 30 days have lost 6.6%. Momentum indicators put RSI at 40.3 (neutral) with MACD reading bearish. Recent trading has carved out support near $27.81 and resistance around $38.85.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 159.0% above the current price.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 87.1%, a beta of 1.04 and a maximum drawdown of 26.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 159.0% above the current price.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 87.1%, a beta of 1.04 and a maximum drawdown of 26.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Benzinga.com25dTectonic Therapeutic Earnings & ForecastsTectonic Therapeutic NASDAQ:TECX reported quarterly losses of $...APEX 24-week Phase 2 trial is evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension...Nasdaq25dTectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business HighlightsWATERTOWN,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 27.11
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 27.11
- Analyst targets imply +159.0% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +159.0% versus the current price
- Negative return on equity of -33.8%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-6.4
ROE-33.80%
ROA-22.29%
Debt/Equity1.97
P/B Ratio2.4
Op. Cash Flow$-72140000
Free Cash Flow$-46723124
Industry P/E30.4
Technical Analysis
TrendBullish
RSI40.3
Support$27.81
Resistance$38.85
MA 20$34.19
MA 50$33.00
MA 200$27.11
MACDBearish
VolumeIncreasing
Fear & Greed Index93.38
Valuation
Target Price$77.56
Upside/Downside159.04%
GradeFair
TypeBlend
Risk Assessment
Beta1.04
Volatility87.07%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.